Antinuclear Antibody (ANA) Test Market By Product (Software & Services, Reagents & Assay Kits and Systems), Technique (Multiplex Assay, Immunofluorescence Assay and ELISA), Application (Scleroderma, Rheumatoid Arthritis, Sjogren’s Syndrome, Systemic Lupus Erythematosus and Other Applications) and End User (Physician Office Laboratories, Hospitals, Clinical Laboratories and Other End Users) - Global Industry Analysis And Forecast To 2025

Industry Outlook

The Antinuclear Antibody (ANA) are the group of autoantibodies that the immune system of a person produces. The test of antinuclear antibody searches for disorders related to autoimmune, for example, rheumatoid arthritis or lupus. The ANA test of blood is only one major player in a medical professional’s diagnosis for autoimmune disease, alongside a posting of your side effects, a physical exam, and different tests. The symptoms for which the doctor prefers the ANA test are tiredness, mild fever, weakness, light sensitivity, hair loss, pain in joint and/or muscle and feeling of tingling & numbness in the feet or hands. Therefore, the Antinuclear Antibody (ANA) Test Market is anticipated to expand and has tremendous scope during the forecast period. The global Antinuclear Antibody (ANA) Test Market anticipated to flourish in the future by growing at a significantly higher CAGR.

Market Segmentation

On the basis of Product the market is segmented into Software & Services, Reagents & Assay Kits and Systems. The Reagents & Assay Kits section is leading the market and is considered as the largest section in the market owing to increasing adoption of the product by research & clinical settings.

On the basis of Technique the market is segmented into Multiplex Assay, Immunofluorescence Assay and ELISA. The Immunofluorescence Assay section is leading the market due to rising adoption of the technique, the technique been more sensitive considered to other techniques, etc.

On the basis of Application the market is segmented into Scleroderma, Rheumatoid Arthritis, Sjogren’s Syndrome, Systemic Lupus Erythematosus and Other Applications. The section Rheumatoid Arthritis is leading the market owing to rising number of cases related to the disease.

On the basis of End User the market is segmented into Physician Office Laboratories, Hospitals, Clinical Laboratories and Other End Users. The Hospitals section is dominating the market owing to more number of the diagnostic examinations carried out here.

Regional Insights

The North American region is leading the global Antinuclear Antibody (ANA) Test Market followed by the European region owing to factors like well-developed healthcare sector, rising awareness amongst the patients, more developed tests present, rising adoption by the people, etc.

Antinuclear Antibody (ANA) Test Market, By Region




North America


U.S.
Canada
Mexico

Europe


Germany
UK
France
Russia
Italy
Rest of Europe

Asia-Pacific


China
Japan
South Korea
India
Southeast Asia
Rest of Asia-Pacific

South America


Brazil
Argentina
Columbia
Rest of South America

Middle East and Africa


Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Rest of MEA


Competitive Analysis

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.


Trinity Biotech PLC
Thermo Fisher Scientific Inc.
Euroimmun AG
Alere Inc.
Erba Diagnostics
Bio-Rad Laboratories.
Inova Diagnostics
Antibodies Inc.
Zeus Scientific
Immuno Concepts


Some of the key questions answered by the report are:


What was the market size in 2014 and forecast from 2015 to 2025?
What will be the industry market growth from 2015 to 2025?
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
What are the major segments leading the market growth and why?
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?